Literature DB >> 16406171

Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults.

Ian F Cook1, Ian Barr, Gunter Hartel, Dimity Pond, Alan W Hampson.   

Abstract

In many countries there is no clear recommendation regarding the preferred route of administration of inactivated influenza vaccines. In a randomised, observer blind study of 720 elderly subjects, a split, trivalent influenza vaccine was significantly more immunogenic for both A strains (H3N2 and H1N1, p = 0.0016 and 0.003, respectively) when given intramuscularly compared to subcutaneously. This difference was due entirely to a gender effect, with females in the intramuscular (IM) group having a significantly greater serological response than females in the subcutaneous (SC) group for both of these strains. Similar results were seen with local adverse effects. These data suggest that vaccination practices that ensure intramuscular injection are required for optimal administration of influenza vaccines in the elderly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16406171     DOI: 10.1016/j.vaccine.2005.11.057

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  43 in total

Review 1.  Effect of vaccine administration modality on immunogenicity and efficacy.

Authors:  Lu Zhang; Wei Wang; Shixia Wang
Journal:  Expert Rev Vaccines       Date:  2015-08-27       Impact factor: 5.217

2.  Gerontology forum: an update on the literature.

Authors: 
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 3.  Sex-based differences in immune function and responses to vaccination.

Authors:  Sabra L Klein; Ian Marriott; Eleanor N Fish
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-01       Impact factor: 2.184

Review 4.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

5.  Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice.

Authors:  Maria E Lorenzo; Andrea Hodgson; Dionne P Robinson; Jenifer B Kaplan; Andrew Pekosz; Sabra L Klein
Journal:  Vaccine       Date:  2011-10-06       Impact factor: 3.641

Review 6.  Sex-based biology and the rational design of influenza vaccination strategies.

Authors:  Sabra L Klein; Andrew Pekosz
Journal:  J Infect Dis       Date:  2014-07-15       Impact factor: 5.226

7.  The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50- to 74-year-old adults.

Authors:  Richard B Kennedy; Whitney L Simon; Michael J Gibson; Krista M Goergen; Diane E Grill; Ann L Oberg; Gregory A Poland
Journal:  Immunology       Date:  2016-05-17       Impact factor: 7.397

Review 8.  A review of factors affecting vaccine preventable disease in Japan.

Authors:  Norimitsu Kuwabara; Michael S L Ching
Journal:  Hawaii J Med Public Health       Date:  2014-12

9.  Subdeltoid/subacromial bursitis associated with influenza vaccination.

Authors:  Ian F Cook
Journal:  Hum Vaccin Immunother       Date:  2013-11-27       Impact factor: 3.452

Review 10.  Targeting the skin for microneedle delivery of influenza vaccine.

Authors:  Dimitrios G Koutsonanos; Richard W Compans; Ioanna Skountzou
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.